Bottom line
How much do BBH and FBDIX overlap?
40% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 58.3% of BBH's assets and 26.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
FBDIX holds far more positions (126 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and FBDIX have in common
| Holding | % of BBH | % of FBDIX | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 4.39% | 4.39% |
| Gilead Sciences Inc | 12.79% | 3.86% | 3.86% |
| Vertex Pharmaceuticals Inc | 9.10% | 3.54% | 3.54% |
| Regeneron Pharmaceuticals Inc | 6.21% | 3.77% | 3.77% |
| Revolution Medicines Inc | 5.27% | 3.01% | 3.01% |
| Argenx SE | 4.97% | 3.62% | 3.62% |
| Insmed Inc | 2.67% | 1.99% | 1.99% |
| Neurocrine Biosciences Inc | 2.08% | 1.82% | 1.82% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
- Moderna Inc — 3.36%
- Illumina Inc — 3.17%
- United Therapeutics Corp — 2.83%
- BeOne Medicines Ltd — 2.81%
- Incyte Corp — 2.49%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- BioMarin Pharmaceutical Inc — 1.34%
- Qiagen Nv — 1.06%
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
- Dianthus Therapeutics, Inc. — 2.32%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- Bridgebio Pharma, Inc. — 1.67%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Amylyx Pharmaceuticals, Inc. — 1.32%
- Eli Lilly & Co. — 1.31%
Asset mix
| Asset type | BBH | FBDIX |
|---|---|---|
| Stocks | 100.0% | 97.0% |
| Cash & short-term funds | 0.1% | 4.6% |
| Preferred stock | — | 1.0% |
| Other | — | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | BBH | FBDIX |
|---|---|---|
| US | 87.3% | 82.0% |
| IE | 1.9% | 6.7% |
| NL | 6.0% | 4.5% |
| CH | 2.8% | 1.2% |
| DK | — | 2.6% |
| DE | 1.9% | 0.8% |
| FR | — | 1.7% |
| GB | — | 1.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BBH and FBDIX overlap?
What stocks do BBH and FBDIX have in common?
Should I own both BBH and FBDIX?
Which holds more stocks, BBH or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.